Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
CALL
Herbalife
HLF
$1.28B
| $1.15M | ﹤0.01% |
21,000
-800
| -4% | -$44.2K |
|
|
CMCM
3452
Cheetah Mobile
CMCM
$94.7M
| $1.15M | ﹤0.01% |
+23,281
| New | +$1.1M |
|
|
RDUS
3453
DELISTED
Radius Recycling
RDUS
| $1.14M | ﹤0.01% |
42,122
+28,226
| +203% | +$845K |
|
|
ESPR
3454
PUT
DELISTED
Esperion Therapeutics
ESPR
| $1.14M | ﹤0.01% |
25,700
+1,800
| +8% | +$82.6K |
|
3455
CALL
Essential Utilities
WTRG
$11.5B
| $1.14M | ﹤0.01% |
30,900
+27,600
| +836% | +$1.02M |
|
3456
CALL
Boston Scientific
BSX
$74.9B
| $1.14M | ﹤0.01% |
29,500
-456,200
| -94% | -$15.9M |
|
|
FTR
3457
DELISTED
Frontier Communications Corp.
FTR
| $1.14M | ﹤0.01% |
174,887
+46,220
| +36% | +$253K |
|
|
ONIT
3458
PUT
Onity Group
ONIT
$330M
| $1.13M | ﹤0.01% |
19,180
+27
| +0.1% | +$1.67K |
|
3459
PUT
Targa Resources
TRGP
$57.2B
| $1.13M | ﹤0.01% |
20,100
+2,500
| +14% | +$133K |
|
3460
Marcus Corp
MCS
$929M
| $1.13M | ﹤0.01% |
26,875
+18,771
| +232% | +$712K |
|
3461
First Busey Corp
BUSE
$2.58B
| $1.13M | ﹤0.01% |
36,355
+24,316
| +202% | +$772K |
|
3462
St. Joe Company
JOE
$3.89B
| $1.13M | ﹤0.01% |
67,092
+20,548
| +44% | +$360K |
|
|
AXDX
3463
CALL
DELISTED
Accelerate Diagnostics
AXDX
| $1.13M | ﹤0.01% |
+4,910
| New | +$1.09M |
|
|
IMMU
3464
PUT
DELISTED
Immunomedics Inc
IMMU
| $1.13M | ﹤0.01% |
54,100
-9,300
| -15% | -$220K |
|
|
CRZO
3465
CALL
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $1.13M | ﹤0.01% |
44,700
-31,800
| -42% | -$821K |
|
|
WIRE
3466
DELISTED
Encore Wire Corp
WIRE
| $1.13M | ﹤0.01% |
22,445
+13,458
| +150% | +$672K |
|
3467
PUT
DXC Technology
DXC
$1.79B
| $1.12M | ﹤0.01% |
12,024
-12,500
| -51% | -$1.11M |
|
3468
Green Plains
GPRE
$1.09B
| $1.12M | ﹤0.01% |
65,333
-11,244
| -15% | -$192K |
|
3469
Central Garden & Pet Co
CENT
$2.78B
| $1.12M | ﹤0.01% |
38,915
+27,512
| +241% | +$902K |
|
3470
Moelis & Co
MC
$5.21B
| $1.12M | ﹤0.01% |
20,447
-15,183
| -43% | -$891K |
|
3471
PUT
Icahn Enterprises
IEP
$5.33B
| $1.12M | ﹤0.01% |
15,800
+11,700
| +285% | +$868K |
|
3472
Preferred Bank
PFBC
$1.28B
| $1.11M | ﹤0.01% |
19,056
+16,878
| +775% | +$1.06M |
|
|
OSG
3473
Octave Specialty Group
OSG
$212M
| $1.11M | ﹤0.01% |
54,351
+37,591
| +224% | +$785K |
|
|
ACIA
3474
PUT
DELISTED
Acacia Communications Inc
ACIA
| $1.11M | ﹤0.01% |
26,800
-3,300
| -11% | -$123K |
|
3475
BOK Financial
BOKF
$8.85B
| $1.11M | ﹤0.01% |
11,386
+9,425
| +481% | +$941K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.